Extracellular vesicles derived from HuMSCs alleviate daunorubicin-induced cardiac microvascular injury via miR-186-5p/PARP9/STAT1 signal pathway
-
Published:2024-03
Issue:
Volume:25
Page:320-330
-
ISSN:2352-3204
-
Container-title:Regenerative Therapy
-
language:en
-
Short-container-title:Regenerative Therapy
Author:
Zhang ShuleORCID,
Li Dong,
Liu Linghong,
Shi Qing,
Ju XiuliORCID
Reference32 articles.
1. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention;Henriksen;Heart,2018
2. Occurrence of treatment-related cardiotoxicity and its impact on outcomes among children treated in the AAML0531 clinical trial: a report from the children's oncology group;Getz;J Clin Oncol,2019
3. Incidence and risk factors for development of cardiac toxicity in adult patients with newly diagnosed acute myeloid leukemia;Boluda;Cancers,2023
4. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association;Lipshultz;Circulation,2013
5. Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort;Dixon;Lancet,2023